纳米氧化铈抗蒽环类药物心肌损伤作用机制研究进展

孟颖月; 韩轩茂<sup>*</sup>; 蔺雪峰

引用本文:	孟颖月,韩轩茂,蔺雪峰.纳米氧化铈抗蒽环类药物心肌损伤作用机制研究进展[J].中国现代应用药学,2023,40(15):2161-2166.
	MENG Yingyue,HAN Xuanmao,LIN Xuefeng.Research Progress on the Mechanism of Cerium Oxide Nanoparticles Against Anthracyclines Myocardial Injury[J].Chin J Mod Appl Pharm(中国现代应用药学),2023,40(15):2161-2166.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 1076次下载 894次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
纳米氧化铈抗蒽环类药物心肌损伤作用机制研究进展
孟颖月¹, 韩轩茂², 蔺雪峰²
1.包头医学院研究生学院, 内蒙古包头 014040;2.内蒙古科技大学包头医学院第一附属医院, 内蒙古包头 014040

摘要:

蒽环类药物产生的剂量依赖性心脏毒性限制了其在肿瘤治疗中的深入应用。最新的动物实验研究表明，纳米氧化铈协同蒽环类药物可以提高其化疗疗效而不增加心脏正常细胞的损伤。本文通过对纳米氧化铈的生物医学性能和蒽环类药物心脏毒性的相关机制进行介绍，就纳米氧化铈在蒽环类药物心脏毒性中的抗氧化应激和抗细胞凋亡作用进行综述，为临床上防治蒽环类药物心脏毒性提供一种可能的策略。

关键词: 蒽环类药物心肌损伤纳米氧化铈

DOI：10.13748/j.cnki.issn1007-7693.20223397

分类号:R966

基金项目:内蒙古自治区自然科学基金项目(2020MS08068，2023MS08040)

Research Progress on the Mechanism of Cerium Oxide Nanoparticles Against Anthracyclines Myocardial Injury

MENG Yingyue¹, HAN Xuanmao², LIN Xuefeng²

1.Graduate School, Baotou Medical College, Baotou 014040, China;2.First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014040, China

Abstract:

Dose-dependent cardiotoxicity of anthracyclines limits its further use in cancer therapy. Recent animal studies have shown that cerium oxide nanoparticles in conjunction with anthracyclines can improve the efficacy of chemotherapy without increasing the damage to normal heart cells. This article introduces the biomedical properties of cerium oxide nanoparticles and the related mechanisms of cardiotoxicity of anthracyclines, and reviews the anti-oxidative stress and anti-apoptosis effects of cerium oxide nanoparticles in the cardiotoxicity of anthracyclines, so as to provide a possible strategy for clinical prevention and treatment of anthracyclines cardiotoxicity.

Key words: anthracyclines myocardial damage cerium oxide nanoparticles